Nkure Therapeutics
PrivateLast Round
Pre Seed
Apr 26, 2023
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Nkure Therapeutics operates in Healthcare & Life Sciences and is based in Bangalore Urban. Its latest recorded funding round was a Pre Seed round in April 2023.
Nkure Therapeutics is a biotechnology company developing affordable natural killer (NK) cell-based immunotherapies for cancer and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nkure Therapeutics Comparables
Compare Nkure Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Century Therapeutics | 75% | |
| Artiva | 74% | |
| Wugen | 73% |
For institutional investors. Book with your work email.
Nkure Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Nkure Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Endiya Partners | Pre Seed |
| Kotak Mahindra Trustee | Pre Seed |
| Innovative Quest Private Limited | Pre Seed |
| Kotak Alternate Asset Managers | Pre Seed |
| Department of Biotechnology | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Grew 25% QoQ, from 12 to 15 employees.
- Aug 21, 2026
Monthly visitors grew 470% MoM to 1.2K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingAug 31, 2026
As of Aug '26, NKure Therapeutics Pvt. Ltd.'s funding totals $2.15M across four rounds: three Seed rounds and one Grant (prize money) round.
For institutional investors. Book with your work email.
Nkure Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nkure Therapeutics's valuation, stock price, and market status.
Is Nkure Therapeutics a public or private company?
Nkure Therapeutics is a private company.
What is the current stock price of Nkure Therapeutics?
Nkure Therapeutics is a private company, so its shares have no public market price. Caplight tracks Nkure Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nkure Therapeutics worth (valuation)?
Valuation information for Nkure Therapeutics is not publicly available.
Can I buy Nkure Therapeutics stock?
Nkure Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nkure Therapeutics's last funding round?
Nkure Therapeutics's most recent funding round was Pre Seed on April 26, 2023.
Who are the main investors in Nkure Therapeutics?
Key investors in Nkure Therapeutics include Endiya Partners, Kotak Mahindra Trustee, Innovative Quest Private Limited, Kotak Alternate Asset Managers, Department of Biotechnology.
Will Nkure Therapeutics IPO soon?
No public IPO plans have been announced for Nkure Therapeutics.
How can I track Nkure Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Nkure Therapeutics's shares on secondary markets.